A Bivalent Molecular Glue Linking Lysine Acetyltransferases to Oncogene-induced Cell Death
Preprint
Abstract
SUMMARY: Developing cancer therapies that induce robust death of the malignant cell is critical to prevent relapse. Highly effective strategies, such as immunotherapy, exemplify this observation. Here we provide the structural and molecular underpinnings for an approach that leverages chemical induced proximity to produce specific cell killing of diffuse large B cell lymphoma, the most common non-Hodgkin’s lymphoma. We develop KAT-TCIPs (lysine acetyltransferase transcriptional/epigenetic chemical inducers of proximity) that redirect p300 and CBP to activate programmed cell death genes normally repressed by the oncogenic driver, BCL6. Acute treatment rapidly reprograms the epigenome to initiate apoptosis and repress c-MYC. The crystal structure of the chemically induced p300-BCL6 complex reveals how chance interactions between the two proteins can be systematically exploited to produce the exquisite potency and selectivity of KAT-TCIPs. Thus, the malignant function of an oncogenic driver can be co-opted to activate robust cell death, with implications for precision epigenetic therapies.Keywords
This publication has 126 references indexed in Scilit:
- Harnessing the TAF1 Acetyltransferase for Targeted Acetylation of the Tumor Suppressor p53Advanced Science, 2024
- A heterobifunctional molecule system for targeted protein acetylation in cells2022
- Current developments in Coot for macromolecular model building of Electron Cryo‐microscopy and Crystallographic DataProtein Science, 2019
- Aberrant Super‐Enhancer Landscape in Human Hepatocellular CarcinomaHepatology, 2019
- MEF2B Instructs Germinal Center Development and Acts as an Oncogene in B Cell LymphomagenesisCancer Cell, 2018
- Master Transcription Factors and Mediator Establish Super-Enhancers at Key Cell Identity GenesCell, 2013
- Histone Recognition and Large-Scale Structural Analysis of the Human Bromodomain FamilyCell, 2012
- Genome-wide Mapping of HATs and HDACs Reveals Distinct Functions in Active and Inactive GenesCell, 2009
- The Mechanism of Action of Cyclosporin A and FK506Clinical Immunology and Immunopathology, 1996
- Calcineurin is a common target of cyclophilin-cyclosporin A and FKBP-FK506 complexesCell, 1991